Arch Pharmalabs Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
1,001
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
6
- Investments
-
3
Arch Pharmalabs General Information
Description
Provider of pharmaceutical products and services. The company's pharmaceutical products and services include small molecule process chemistry and custom synthesis services, enabling its clients in the global pharmaceutical industry to get tailored products and services that have been created to meet their particular needs.
Contact Information
Website
www.archpharmalabs.comCorporate Office
- Unit: 503/505, Hyde Park
- Saki Vihar Road, Opposite to Ansa Industrial Estate, Andheri East
- Mumbai, Maharashtra 400072
- India
Corporate Office
- Unit: 503/505, Hyde Park
- Saki Vihar Road, Opposite to Ansa Industrial Estate, Andheri East
- Mumbai, Maharashtra 400072
- India
Arch Pharmalabs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arch Pharmalabs Patents
Arch Pharmalabs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020016903-A1 | An improved and commercially viable process for preparation of pyrrole derivatives with improved impurity profile & minimisation of unit operations. | Inactive | 18-Jul-2018 | ||
| WO-2013093928-A1 | An improved process for preparing 2-oxindoles of formula i, a key raw material for making pharmaceutical drugs and intermediates thereof | Inactive | 20-Dec-2011 | ||
| WO-2013080215-A1 | An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof | Inactive | 30-Nov-2011 | ||
| WO-2013011518-A1 | Process for the preparation of retigabine of the formula i and pharmaceutically acceptable salts thereof | Inactive | 21-Jul-2011 | ||
| WO-2012153341-A1 | A process for the preparation of iloperidone and pharmaceutically acceptable salts thereof | Inactive | 12-May-2011 | C07D231/56 |
Arch Pharmalabs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arch Pharmalabs Investments & Acquisitions (3)
Arch Pharmalabs’s most recent deal was a Buyout/LBO with Benzochem Lifesciences for . The deal was made on 09-Jun-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Benzochem Lifesciences | 09-Jun-2008 | Buyout/LBO | Pharmaceuticals | ||
| Kobo Biotech | 04-Nov-2007 | PIPE | Pharmaceuticals | ||
| Watsol Organics | 22-Aug-2007 | Merger/Acquisition | Industrial Chemicals |
Arch Pharmalabs Exits (1)
Arch Pharmalabs’s most recent exit was on 04-Nov-2007 from Kobo Biotech. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Kobo Biotech | 04-Nov-2007 | Completed |
|
Arch Pharmalabs FAQs
-
When was Arch Pharmalabs founded?
Arch Pharmalabs was founded in 1999.
-
Where is Arch Pharmalabs headquartered?
Arch Pharmalabs is headquartered in Mumbai, India.
-
What is the size of Arch Pharmalabs?
Arch Pharmalabs has 1,001 total employees.
-
What industry is Arch Pharmalabs in?
Arch Pharmalabs’s primary industry is Pharmaceuticals.
-
Is Arch Pharmalabs a private or public company?
Arch Pharmalabs is a Private company.
-
What is Arch Pharmalabs’s current revenue?
The current revenue for Arch Pharmalabs is .
-
How much funding has Arch Pharmalabs raised over time?
Arch Pharmalabs has raised $65M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
